BBI Solutions
UK-based manufacturer of gold colloid and lateral flow assay reagents; headquartered in Crumlin, South Wales; ISO 13485:2015 certified; supplies gold nanoparticles used in over 500 million diagnostic assays globally per year; pioneer in commercial colloidal gold production for 30+ years; offers proprietary large-batch manufacturing with high particle uniformity; acquired IBEX Technologies (Canada) in 2024 and Biotez GmbH (Germany) to expand biochemistry capabilities; key supplier to Roche, Abbott, Siemens Healthineers and other major IVD manufacturers